MEDx received 33 outstanding applications in response to its Biomedical Research RFA.
The following ten projects have been funded thanks to matching funds from the School of Medicine, from the departments of Biomedical Engineering and Mechanical Engineering and Material Science, Bioinformatics and Biostatistics, Pathology, Dermatology, and Psychiatry, from the Division of Cell Therapy in the Department of Medicine and from the Duke Cardiovascular Research Center.
“The development of a novel platform mimicking the human placental barrier,” led by George Truskey (BME), Liping Feng (ObGyn), and Sallie Permar (Pediatrics).
“Development of defined matrices for lung alveolar epithelial stem cell organoid culture,” led by Ashutosh Chilkoti (BME), Purushothama Rao Tata (Cell Biology), and Christina Barkauskas (Medicine).
“Development and validation of an acoustofluidic chip for exosome isolation,” led by Tony Jun Huang (MEMS) and W. Daniel Stamer (Ophthalmology).
“Novel substrates of Mesh1 in the stress tolerance of engineered human cardiomyocytes,” led by Nenad Bursac (BME) and Jen-Tsan Ashley Chi (Molecular Genetics & Microbiology).
“Injectable depots of unimolecular, dual incretins for treatment of Type 2 Diabetes,” led by Ashutosh Chilkoti (BME) and Jonathan Campbell (Medicine).
“Real-time molecular credentialing of Her2 levels in breast tumor tissue and blood,” led by Ashutosh Chilkoti (BME) and Kris Wood (Pharmacology & Cancer Biology).
“Recombinant elastin-like polypeptides for therapeutic heart regeneration,” led by Ashutosh Chilkoti (BME) and Ravi Karra (Cardiology).
“Photoaccoustic imaging of microvasculature in cutaneous small vessel vasculitis,” led by Junjie Yao (BME) and Adela Rambi G. Cardones (Dermatology).
“Next generation electrode for megascale neural recordings,” led by Nenad Bursac (BME) and Kafui Dzirasa (Psychiatry).
“Generation of 3D-vascularized microenvironments to assess hematopoietic responses,” led by Jennifer West (BME) and Phuong Doan (Medical Oncology).